4,0
18. Apr. 2013
Aktueller Mitarbeiter, mehr als 10 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good salaries, collaborative environment, the RAs are still getting stocks/options from Roche (parent company), awesome benefits and a robust pipeline.
Kontras
There is an attempt for "360 reviews" where the employees can review their boss. In many cases, this has led to retribution from the boss -- Upper management needs to think if the benefits outweigh the costs here.